/
GLUC
$0.49-$0.04 (-7.50%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.02 – $0.67
73% from low
Exchange
OTC Link
CS
Borrow rate
13.32%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-1.16
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $197.5K | $291.2K | $480.7K | $953.7K | $1.1M | $534.7K | $384.1K | $340.7K |
| Cost of revenue | $144.7K | $238.5K | $307.2K | $543.6K | $615.9K | $319.0K | $308.5K | $221.4K |
| Gross profit | $52.8K | $52.7K | $173.5K | $410.0K | $456.7K | $215.8K | $75.5K | $119.2K |
| Gross margin | 26.7% | 18.1% | 36.1% | 43.0% | 42.6% | 40.3% | 19.7% | 35.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $5.5K | $0 |
| Operating income | −$23.5K | −$230.1K | −$564.4K | −$336.1K | −$562.1K | −$422.0K | −$306.6K | −$199.8K |
| EBITDA | −$23.4K | −$200.5K | −$563.6K | −$336.1K | −$562.1K | −$421.9K | −$305.5K | −$197.2K |
| Net income | −$47.1K | −$246.2K | −$581.4K | −$338.9K | −$562.1K | −$422.0K | −$315.9K | −$230.7K |
| Net margin | -23.8% | -84.5% | -121.0% | -35.5% | -52.4% | -78.9% | -82.3% | -67.7% |
| EPS (diluted) | -0.01 | -0.03 | -0.05 | -0.03 | -0.05 | -0.03 | -0.03 | -0.02 |
Annual figures · source: Financial Modeling Prep
Peer comparison
GLUCOSE HEALTH INC
GLUCOSE HEALTH INC
Held by traders on TradeandTell
No one on the platform currently holds GLUC.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GLUC as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded GLUC yet.
